CERUS CORP.CERUS CORP.CERUS CORP.

CERUS CORP.

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
−0.04EUR
Revenue estimate
‪40.06 M‬EUR
Market capitalization
‪288.98 M‬EUR
−0.1890EUR
‪−33.97 M‬EUR
‪141.67 M‬EUR
‪171.96 M‬
Beta (1Y)
3.87

About Cerus Corporation

CEO
William Mariner Greenman
Website
Headquarters
Concord
Employees (FY)
288
Founded
1991
FIGI
BBG000KSP427
Cerus Corp. engages in the research, development, and manufacturing of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange CERUS CORP. stocks are traded under the ticker CU2.
CERUS CORP. is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
CU2 earnings for the last quarter are −0.04 EUR per share, whereas the estimation was −0.05 EUR resulting in a 25.00% surprise. The estimated earnings for the next quarter are −0.02 EUR per share. See more details about CERUS CORP. earnings.
CERUS CORP. revenue for the last quarter amounts to ‪44.75 M‬ EUR despite the estimated figure of ‪46.10 M‬ EUR. In the next quarter revenue is expected to reach ‪48.53 M‬ EUR.
Yes, you can track CERUS CORP. financials in yearly and quarterly reports right on TradingView.
CU2 net income for the last quarter is ‪−1.20 M‬ EUR, while the quarter before that showed ‪−6.87 M‬ EUR of net income which accounts for 82.50% change. Track more CERUS CORP. financial stats to get the full picture.
No, CU2 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CU2 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CERUS CORP. stock right from TradingView charts — choose your broker and connect to your account.
CU2 reached its all-time high on Aug 24, 2020 with the price of 7.8000 EUR, and its all-time low was 1.1406 EUR and was reached on Oct 19, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 28, 2024, the company has 288.00 employees. See our rating of the largest employees — is CERUS CORP. on this list?
We've gathered analysts' opinions on CERUS CORP. future price: according to them, CU2 price has a max estimate of 5.63 EUR and a min estimate of 1.88 EUR. Read a more detailed CERUS CORP. forecast: see what analysts think of CERUS CORP. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CERUS CORP. EBITDA is ‪−48.11 M‬ EUR, and current EBITDA margin is −34.76%. See more stats in CERUS CORP. financial statements.